A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study

PHASE3CompletedINTERVENTIONAL
Enrollment

1,600

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

June 30, 2006

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal (vaccine)

Trial Locations (35)

15140

GSK Investigational Site, Lahti

20520

GSK Investigational Site, Turku

27300

GSK Investigational Site, Bernay

28120

GSK Investigational Site, Pori

33200

GSK Investigational Site, Tampere

40100

GSK Investigational Site, Jyväskylä

GSK Investigational Site, Dax

48100

GSK Investigational Site, Kotka

54270

GSK Investigational Site, Essey-lès-Nancy

60100

GSK Investigational Site, Seinäjoki

67100

GSK Investigational Site, Kokkola

70100

GSK Investigational Site, Kuopio

75019

GSK Investigational Site, Paris

76000

GSK Investigational Site, Rouen

76150

GSK Investigational Site, Maromme

76600

GSK Investigational Site, Le Havre

83300

GSK Investigational Site, Draguignan

90100

GSK Investigational Site, Oulu

92400

GSK Investigational Site, Courbevoie

92701

GSK Investigational Site, Colombes

94000

GSK Investigational Site, Créteil

94130

GSK Investigational Site, Nogent-sur-Marne

02100

GSK Investigational Site, Espoo

GSK Investigational Site, Saint-Quentin

00930

GSK Investigational Site, Helsinki

04400

GSK Investigational Site, Järvenpää

01300

GSK Investigational Site, Vantaa

01600

GSK Investigational Site, Vantaa

06300

GSK Investigational Site, Nice

85-021

GSK Investigational Site, Bydgoszcz

39-200

GSK Investigational Site, Dębica

31-202

GSK Investigational Site, Krakow

61-709

GSK Investigational Site, Poznan

41-103

GSK Investigational Site, Siemianowice Śląskie

55-100

GSK Investigational Site, Trzebnica

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00307554 - A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study | Biotech Hunter | Biotech Hunter